V7B1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Assembly Biosciences Inc

Watchlist Manager

Watchlist

Price: 3.2 EUR 8.11% Market Closed

Market Cap: €52.4m

A	Assembly Biosciences Inc F:V7B1	US
C	Clean Power Hydrogen PLC F:G9Z	UK
C	Commerzbank AG XBER:CBK	DE
	Pulmatrix Inc F:2PU	US
M	Metro Inc F:62M	CA
	Wacker Neuson SE F:WAC	DE
	Tactile Systems Technology Inc NASDAQ:TCMD	US
L	Lockheed Martin Corp XBER:LOM	US
G	Galderma Group AG OTC:GDERF	CH
A	Amerisourcebergen Corp LSE:0HF3	US
A	Asahi Group Holdings Ltd XBER:ABW	JP
P	Pfizer Inc F:PFE	US
V	Volkswagen AG SIX:VW.V	DE

Profitability Summary

Assembly Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-17%

Negative 3Y Average Operating Margin

-255%

Negative Net Margin

-8%

Negative 3Y Average Net Margin

-234%

Negative Free Cash Flow Margin

-57%

Negative 3Y Average Free Cash Flow Margin

-1%

Negative ROE

-5%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-772%

ROIC is Increasing

-553% > -164%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.